Found 4 results

↓ CSV
Name Type of Offering Accepted Date
N30 Pharmaceuticals, Inc. See All Filings
D 2014-11-24
Amount To Be Raised $40,000,000
Associated Brokers / Dealers N/A
CIK Number 0001626199
Filed Document 0001626199-14-000001
Exclusions or Exemptions 506b
Accepted Date 2014-11-24
Type of Offering D
Industry Pharmaceuticals
Offering Tier N/A
Principal Place of Business COLORADO
Revenue or Assets Decline to Disclose
Type of Security Equity
ALPINE IMMUNE SCIENCES, INC. See All Filings
D 2019-01-30 15:09:11
Amount To Be Raised $48,660,651
Associated Brokers / Dealers N/A
CIK Number 0001626199
Filed Document 0001626199-19-000001
Exclusions or Exemptions 506b
Accepted Date 2019-01-30 15:09:11
Type of Offering D
Industry Biotechnology
Offering Tier N/A
Principal Place of Business WASHINGTON
Revenue or Assets Decline to Disclose
Type of Security Equity
ALPINE IMMUNE SCIENCES, INC. See All Filings
D 2020-08-07 14:20:30
Amount To Be Raised $82,666,486
Associated Brokers / Dealers N/A
CIK Number 0001626199
Filed Document 0001626199-20-000038
Exclusions or Exemptions 506b
Accepted Date 2020-08-07 14:20:30
Type of Offering D
Industry Biotechnology
Offering Tier N/A
Principal Place of Business WASHINGTON
Revenue or Assets Decline to Disclose
Type of Security Equity
ALPINE IMMUNE SCIENCES, INC. See All Filings
D 2021-09-29 16:23:50
Amount To Be Raised $91,003,125
Associated Brokers / Dealers N/A
CIK Number 0001626199
Filed Document 0001626199-21-000132
Exclusions or Exemptions 506b
Accepted Date 2021-09-29 16:23:50
Type of Offering D
Industry Biotechnology
Offering Tier N/A
Principal Place of Business WASHINGTON
Revenue or Assets Decline to Disclose
Type of Security Equity